DVLP is focused on creating a new infrastructure for drug development by digitizing drug assets, financing, and development workflows. The platform aims to streamline the drug development process using AI and blockchain technology.

DVLP

DVLP Medicines | 103 followers on LinkedIn. DVLP is digital drug development. | DVLP Medicines: Building a New Infrastructure for Drug Development
At DVLP Medicines, we&#39;re building a new infrastructure for drug development on the blockchain, leveraging the power of AI and blockchain technology. We&#39;re reimagining the entire drug development process to accelerate the journey from molecule to medicine.
Our innovative platform digitizes drug assets, financing, and drug development process optimization, enabling secure, transparent, and efficient collaboration among scientists, investors, experts, regulators, and key industry players.

Jason Mauk

General Partner, DCVC

Jason Pontin

DVLP Medicines

Our CEO and Founder Jason Paragas at the NYSE representing DVLP Medicines as our dear friends at DCVC and the Super Founders Club rang the closing bell. #nyse #ourjourney #innovation #ai helping bring #medicines to #patients who need them / DVLP / 🧬🩺💡

DVLP Medicines is pleased to announce the appointment of Florencio Mazzoldi as #CTO . Florencio brings a wealth of experience in #pharmaceutical #innovation , #digitaltransformation , and strategic technology leadership to the DVLP team. With an impressive track record of driving technological advancements from notable companies such as Ginkgo Bioworks, Inc. and Autodesk , Florencio is set to play a critical role in advancing DVLP’s mission. His deep expertise in leading large-scale projects and fostering cross-functional collaborations will accelerate our efforts in delivering breakthrough treatments to market. CEO Jason Paragas commented, “Florencio’s vision and technical expertise are perfectly aligned with our goal to automate #drugdevelopment . His leadership will help us scale our capabilities and maintain our commitment to excellence.” Florencio Mazzoldi joins DVLP Medicines at a pivotal time, and we are confident that his leadership will enable us to realize the vision of "automating drug development and letting us open the first marketplace for drug development." Please join us in welcoming Florencio to the DVLP Medicines family!

We are thrilled to share that our design system, developed in collaboration with One Design Company , has been honored by Graphis Inc. The award is a testament to our commitment to technology-driven innovation in the pharmaceutical industry. Working alongside David Sieren and the team has been an incredible journey towards shaping the future of medicines with innovation, substance and durability. #pharma #drugdiscovery #pharma #aidrugdiscovery https://lnkd.in/ea-KQJ2x

At DVLP Medicines , we take a moment to remember and honor the men and women who gave their lives in service to our country. This Memorial Day, as we continue to face new challenges and technologies reshaping our world, it's important to reflect on the true meaning of this day. Let's take a moment to honor the brave individuals who made the ultimate sacrifice to defend our Nation and its ideals of freedom and liberty. Follow the link below to learn more about the history of Memorial Day. #MemorialDay #HonorTheFallen Link: https://lnkd.in/dfUKf4E

Excited to represent DVLP Medicines on the Collaboration and Success Stories panel at the Chicago Life Science Summit and the opportunity to explore the future with my long time thought partner David Sieren from One Design Company and dialog with other panel members! https://lnkd.in/eUC9R-Bp

Jason Paragas

https://lnkd.in/gpFznJwV At DVLP Medicines we are excited to put cryptography to work for operational efficiencies during the complex and costly drug development phase. A great thought piece from our partner, DCVC on practical crypto. #blockchain #drugdevelopment

SSL by Default

HSTS

Amazon

nginx

Amazon CloudFront

Amazon SSL

Next.js

Material-UI

AWS Cloudfront Chicago IL Edge

Amazon WAF Blocked

Chief Executive Officer and Founder

Palo Alto Companies

California Medical Companies (Top 10K)

Pharmaceutical Companies With Fewer Than 100 Employees (Top 10K)

Silicon Valley Companies With Fewer Than 50 Employees (Top 10K)

DVLP Medicines operates as a pioneering entity in the pharmaceutical sector by leveraging blockchain technology to revolutionize drug development. The company focuses on digitizing drug assets to streamline the financing and development process, aiming to enhance the efficiency of bringing therapeutics to market. By integrating science and finance through a digital marketplace, DVLP Medicines seeks to optimize the drug development lifecycle, from initial molecule discovery to market readiness. This innovative approach addresses the traditional challenges of drug development by offering a new infrastructure that facilitates easier access to capital and resources.

Palo Alto

California

United States

North America

A digital platform that digitizes drug assets, financing, and development workflows, enabling the transformation of molecules into medicines through AI and blockchain technology.

A digital platform that digitizes drug assets, automates the development process using AI and blockchain, and facilitates investment in specific drug assets.

Decentralized digital entities dedicated to advancing a single drug asset through the development process, facilitating collaboration among stakeholders.

Digital entities dedicated to advancing a single drug asset through development, allowing for decentralized collaboration among stakeholders.

Sweden

Europe

Romania

Indonesia

Asia

Bangladesh

DVLP is building a new infrastructure for drug development by digitizing drug assets, financing, and development workflows to accelerate the process of turning molecules into medicines.

news impact assignment basic	general
public peers	general	Nov 11, 2024 6:33 PM	02b340cb
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 11, 2024 6:33 PM	0173d2da
crunchbase trigger	general	Nov 27, 2024 12:50 PM	33b5e7cc
crunchbase profile	general	Nov 27, 2024 8:52 PM	241b4ba9
li profile	general	Nov 11, 2024 6:33 PM	b3bdfe80
translate crunchbase fundingrounds	general	Nov 27, 2024 10:25 PM	967be902
peers	general	Nov 11, 2024 6:33 PM	36150872
news basic	general	Nov 11, 2024 6:33 PM	284009c5
bundesanzeiger	filings
financials download nd	financials
private financials	financials

DVLP

COM:DVLPMEDICINES

DVLP